Literature DB >> 25829088

Multiple myeloma.

Patrick J Peller1.   

Abstract

This article presents a review of multiple myeloma, precursor states, and related plasma cell disorders. The clinical roles of fluorodeoxyglucose PET/computed tomography (CT) and the potential to improve the management of patients with multiple myeloma are discussed. The clinical and research data supporting the utility of PET/CT use in evaluating myeloma and other plasma cell dyscrasias continues to grow.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fluorodeoxyglucose; Monoclonal gammopathy; Multiple myeloma; PET; PET/CT; Plasmacytoma

Mesh：

Substances：

Year:  2015        PMID： 25829088     DOI： 10.1016/j.cpet.2014.12.008

Source DB:  PubMed          Journal:  PET Clin        ISSN： 1556-8598


  3 in total

Review 1.  Identification of MicroRNAs With In Vivo Efficacy in Multiple Myeloma-related Xenograft Models.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

2.  Expression level of miRNA in the peripheral blood of patients with multiple myeloma and its clinical significance.

Authors:  Guangbao Li; Jianwen Yin; Zutong Wu; Shizhong Li; Aijun He; Zhenzhen Sun
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

3.  Expression of hsa-MIR-204, RUNX2, PPARγ, and BCL2 in Bone Marrow Derived Mesenchymal Stem Cells from Multiple Myeloma Patients and Normal Individuals.

Authors:  Raziyeh Mansurabadi; Saeid Abroun; Abass Hajifathali; Amir Asri; Amir Atashi; Mansoureh Haghighi
Journal:  Cell J       Date:  2017-05-17       Impact factor: 2.479
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.